Bianca Mostert

2.5k total citations
65 papers, 1.4k citations indexed

About

Bianca Mostert is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Bianca Mostert has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 33 papers in Surgery and 31 papers in Oncology. Recurrent topics in Bianca Mostert's work include Esophageal Cancer Research and Treatment (22 papers), Cancer Genomics and Diagnostics (22 papers) and Gastric Cancer Management and Outcomes (20 papers). Bianca Mostert is often cited by papers focused on Esophageal Cancer Research and Treatment (22 papers), Cancer Genomics and Diagnostics (22 papers) and Gastric Cancer Management and Outcomes (20 papers). Bianca Mostert collaborates with scholars based in Netherlands, Belgium and United States. Bianca Mostert's co-authors include Stefan Sleijfer, John A. Foekens, Jan W. Gratama, Anieta M. Sieuwerts, John W.M. Martens, Jaco Kraan, Joan Bolt‐de Vries, Petra van der Spoel, Jan‐Willem Gratama and Petronella G. Pieper and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bianca Mostert

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bianca Mostert Netherlands	19	828	621	375	312	246	65	1.4k
Tomasz Świtaj Poland	20	616 0.7×	154 0.2×	687 1.8×	291 0.9×	234 1.0×	109	1.4k
Federica Recine Italy	19	657 0.8×	204 0.3×	441 1.2×	234 0.8×	246 1.0×	57	1.2k
Hubing Wu China	21	493 0.6×	272 0.4×	338 0.9×	162 0.5×	343 1.4×	100	1.4k
Shigeto Ueda Japan	20	531 0.6×	508 0.8×	215 0.6×	267 0.9×	96 0.4×	43	1.4k
J. Doyen France	22	716 0.9×	617 1.0×	661 1.8×	520 1.7×	294 1.2×	101	1.9k
Koh‐ichi Sakata Japan	22	498 0.6×	203 0.3×	321 0.9×	303 1.0×	496 2.0×	85	1.4k
Michael Tachezy Germany	26	1.1k 1.4×	547 0.9×	574 1.5×	477 1.5×	603 2.5×	69	1.8k
Carlo Milandri Italy	15	677 0.8×	273 0.4×	261 0.7×	141 0.5×	114 0.5×	53	936
Antonio Cubillo Spain	18	864 1.0×	233 0.4×	253 0.7×	208 0.7×	248 1.0×	88	1.1k
Youlia Kirova France	18	466 0.6×	691 1.1×	307 0.8×	129 0.4×	196 0.8×	50	1.3k

Countries citing papers authored by Bianca Mostert

Since Specialization

Citations

This map shows the geographic impact of Bianca Mostert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bianca Mostert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bianca Mostert more than expected).

Fields of papers citing papers by Bianca Mostert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bianca Mostert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bianca Mostert. The network helps show where Bianca Mostert may publish in the future.

Co-authorship network of co-authors of Bianca Mostert

This figure shows the co-authorship network connecting the top 25 collaborators of Bianca Mostert. A scholar is included among the top collaborators of Bianca Mostert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bianca Mostert. Bianca Mostert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klaveren, David van, Sjoerd M. Lagarde, Hester F. Lingsma, et al.. (2025). Accuracy of Predicting Residual Disease and Disease Progression During Active Surveillance for Esophageal Cancer. Annals of Surgical Oncology. 33(2). 946–954.

Noort, Vincent van der, Valesca P. Retèl, Irene E.G. van Hellemond, et al.. (2025). 2096MO Systemic therapy, gastrectomy and CRS/HIPEC vs systemic therapy alone for gastric cancer with limited peritoneal dissemination: Results of the randomised PERISCOPE II trial. Annals of Oncology. 36. S1102–S1103.

Klaveren, David van, Sjoerd M. Lagarde, Hester F. Lingsma, et al.. (2025). 252. ACCURACY OF PREDICTING RESIDUAL DISEASE AND DISEASE PROGRESSION DURING ACTIVE SURVEILLANCE FOR ESOPHAGEAL CANCER. Diseases of the Esophagus. 38(Supplement_1).

Noordman, Bo Jan, H. de Graaf, Irene E.G. van Hellemond, et al.. (2025). The prognostic value of peritoneal metastases in patients with gastric cancer: a nationwide population-based study. EClinicalMedicine. 81. 103109–103109. 1 indexed citations

Buisman, Florian E., Rutger‐Jan Swijnenburg, Bianca Mostert, et al.. (2025). Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 Trial. Journal of Clinical Oncology. 44(6). 455–465.

Sluis, Pieter C. van der, Bianca Mostert, Joost J. Nuyttens, et al.. (2024). Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy. Annals of Surgical Oncology. 31(6). 3813–3818. 1 indexed citations

Narayan, Raja R., Marc G. Besselink, Casper H.J. van Eijck, et al.. (2024). Chemotherapy switch for localized pancreatic cancer: a systematic review and meta-analysis. British journal of surgery. 111(10). 3 indexed citations

Velzen, M.J.M. van, Mirjam A. G. Sprangers, Jessy Joy van Kleef, et al.. (2024). Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal Cancer. Journal of the National Comprehensive Cancer Network. 22(7). 455–461. 2 indexed citations

Vissers, Pauline A. J., Rob H.A. Verhoeven, Bianca Mostert, et al.. (2024). Patient access to perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel in patients with resectable gastric cancer in the Netherlands. European Journal of Cancer. 214. 115137–115137. 2 indexed citations

10.

Verhoeven, Rob H.A., Marije Slingerland, Bas P. L. Wijnhoven, et al.. (2024). 438P Adjuvant nivolumab after neoadjuvant chemoradiotherapy and surgery for patients with esophageal or gastroesophageal junction cancer: A nationwide real-world matched comparison of overall survival. Annals of Oncology. 35. S176–S177. 1 indexed citations

11.

With, Mirjam de, Leni van Doorn, Esther Oomen‐de Hoop, et al.. (2023). Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD. Biomedicine & Pharmacotherapy. 159. 114232–114232. 13 indexed citations

12.

Mostert, Bianca, Jaco Kraan, Vanja de Weerd, et al.. (2023). mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer. Molecular Oncology. 17(9). 1898–1907. 5 indexed citations

13.

Sluis, P. van der, Manon C.W. Spaander, Grard A. P. Nieuwenhuijzen, et al.. (2023). P-391 Perioperative chemotherapy for operable gastro-esophageal or gastric cancer: Anthracycline triplets versus FLOT. Annals of Oncology. 34. S150–S150. 1 indexed citations

14.

Jolissaint, Joshua S., Lynn E. Nooijen, Andrea Cercek, et al.. (2023). ASO Visual Abstract: Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 31(2). 1296–1297. 4 indexed citations

15.

Eyck, Ben M., Maurice P.H.M. Jansen, Bo Jan Noordman, et al.. (2022). Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer. The Journal of Pathology. 259(1). 35–45. 9 indexed citations

16.

Verduijn, Gerda M., Juan A. Hernández‐Tamames, Wilma D. Heemsbergen, et al.. (2022). The COMPLETE trial: HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study. BMJ Open. 12(5). e059345–e059345. 1 indexed citations

17.

Sieuwerts, Anieta M., Esther Oomen‐de Hoop, Bianca Mostert, et al.. (2019). Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer. European Journal of Cancer. 121. 48–54. 23 indexed citations

18.

Mostert, Bianca, Anieta M. Sieuwerts, Joan Bolt‐de Vries, et al.. (2015). mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients. Molecular Oncology. 9(4). 920–932. 39 indexed citations

19.

Onstenk, Wendy, Jaco Kraan, Bianca Mostert, et al.. (2014). Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy. Molecular Cancer Therapeutics. 14(3). 821–827. 47 indexed citations

20.

Mostert, Bianca, Anieta M. Sieuwerts, Jaco Kraan, et al.. (2014). Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients. Annals of Oncology. 26(3). 510–516. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact